154.10

3.23% -5.15

After Hours: 154.40 0.30 +0.19%

Iqvia Holdings Inc (IQV)

Overview News Price History Option Chain Financials Discussions Forecast

Iqvia Holdings Inc stock is traded at $154.10, with a volume of 2.63M. It is down -3.23% in the last 24 hours and up +7.90% over the past month. Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Previous Close:

$159.25

Open:

$157.45

24h Volume:

2.63M

Relative Volume:

1.15

Market Cap:

$27.64B

Revenue:

$15.50B

Net Income/Loss:

$1.33B

P/E Ratio:

20.99

EPS:

7.34

Net Cash Flow:

$2.16B

1W Performance:

-3.55%

1M Performance:

+7.90%

6M Performance:

-21.63%

1Y Performance:

-27.76%

1-Day Range:

$153.22

$158.99

1-Week Range:

$153.22

$163.79

52-Week Range:

$134.65

$252.88

Iqvia Holdings Inc Stock (IQV) Company Profile

Name

Iqvia Holdings Inc

Sector

Healthcare (1172)

Industry

Diagnostics & Research (54)

Phone

919-998-2000

Address

2400 ELLIS ROAD, DURHAM, NC

Employee

89,000

Twitter

@IQVIA_global

Next Earnings Date

2024-10-31

Latest SEC Filings

IQV's Discussions on Twitter

Compare IQV with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IQV Iqvia Holdings Inc	154.10	27.64B	15.50B	1.33B	2.16B	7.34
TMO Thermo Fisher Scientific Inc	390.26	156.49B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	195.75	145.01B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	520.59	42.30B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	116.09	34.24B	6.63B	1.17B	1.19B	4.05

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-25-25	Downgrade	HSBC Securities	Buy → Hold
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform
Jul-24-24	Downgrade	Jefferies	Buy → Hold
Jun-06-24	Initiated	Goldman	Buy
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-06-23	Initiated	HSBC Securities	Buy
Mar-17-23	Initiated	Truist	Buy
Dec-06-22	Initiated	Cowen	Outperform
Nov-17-22	Downgrade	Citigroup	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-15-22	Initiated	SVB Leerink	Outperform
May-24-22	Initiated	Guggenheim	Buy
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-05-21	Resumed	Credit Suisse	Outperform
Apr-16-21	Upgrade	Stephens	Equal-Weight → Overweight
Mar-08-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-03-21	Initiated	Barclays	Overweight
Jul-07-20	Initiated	Stephens	Equal-Weight
Mar-02-20	Initiated	Deutsche Bank	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Dec-13-19	Upgrade	CFRA	Sell → Hold
Nov-14-19	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-21-19	Upgrade	Mizuho	Neutral → Buy
May-28-19	Initiated	SVB Leerink	Outperform
Jan-18-19	Upgrade	Jefferies	Hold → Buy
Oct-09-18	Initiated	UBS	Buy
Oct-02-18	Reiterated	Robert W. Baird	Outperform
Jul-25-18	Upgrade	BofA/Merrill	Neutral → Buy
Jul-25-18	Reiterated	Stifel	Buy
Jul-03-18	Upgrade	Raymond James	Outperform → Strong Buy
Apr-13-18	Upgrade	Goldman	Neutral → Buy
Mar-07-18	Upgrade	SunTrust	Hold → Buy
Jan-19-18	Initiated	Evercore ISI	Outperform

View All

Iqvia Holdings Inc Stock (IQV) Latest News

06:19 AM

Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating - marketscreener.com

06:19 AM

05:50 AM

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) - Yahoo Finance

05:50 AM

Jun 16, 2025

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’ - Business Wire

Jun 16, 2025

Jun 15, 2025

Learn to Evaluate (IQV) using the Charts - news.stocktradersdaily.com

Jun 15, 2025

Jun 13, 2025

IQVIA Holdings Stock: Is IQV Underperforming the Healthcare Sector? - MSN

Jun 13, 2025

Park Avenue Securities LLC Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - Defense World

Jun 13, 2025

Jun 12, 2025

IQVIA Completes $2 Billion Senior Notes Offering - Global Legal Chronicle

Jun 12, 2025

Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - Benzinga

Jun 12, 2025

Jun 11, 2025

IQVIA unveils AI agents for life sciences using NVIDIA technology By Investing.com - Investing.com South Africa

Jun 11, 2025

IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN

Jun 11, 2025

IQVIA Launches New AI Agents for Life Sciences and Healthcare - marketscreener.com

Jun 11, 2025

IQVIA unveils AI agents for life sciences using NVIDIA technology - Investing.com Australia

Jun 11, 2025

Jun 10, 2025

IQVIA Holdings Stock: Is IQV Underperforming The Healthcare Sector? - Barchart.com

Jun 10, 2025

IQVIA Stock: Stuck In A Time SpiralValue Play Or Bull Trap? - Benzinga

Jun 10, 2025

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week - Yahoo Finance

Jun 10, 2025

IQVIA prices $2 billion senior notes offering By Investing.com - Investing.com South Africa

Jun 03, 2025